BDBM193737 1-(3-(2-(2,4-Dioxopentan-3-ylidene)hydrazinyl)phenyl)-5-phenyl-N3,N4-bis(5-sulfamoyl-1,3,4-thiadiazol-2-yl)-1H-pyrazole-3,4-dicarboxamide (5)

SMILES: [#6]-[#6](=O)-[#6](=[#7]/[#7]-c1cccc(c1)-n1nc(-[#6](=O)-[#7]-c2nnc(s2)S([#7])(=O)=O)c(-[#6](=O)-[#7]-c2nnc(s2)S([#7])(=O)=O)c1-c1ccccc1)\[#6](-[#6])=O

InChI Key: InChIKey=PCILGPUQPGAMSC-UHFFFAOYSA-N

Data: 2 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 193737   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Carbonic anhydrase 2 (Homo sapiens (Human))	BDBM193737 (1-(3-(2-(2,4-Dioxopentan-3-ylidene)hydrazinyl)phen...) Show SMILES [#6]-[#6](=O)-[#6](=[#7]/[#7]-c1cccc(c1)-n1nc(-[#6](=O)-[#7]-c2nnc(s2)S([#7])(=O)=O)c(-[#6](=O)-[#7]-c2nnc(s2)S([#7])(=O)=O)c1-c1ccccc1)\[#6](-[#6])=O Show InChI InChI=1S/C26H22N12O8S4/c1-12(39)18(13(2)40)32-31-15-9-6-10-16(11-15)38-20(14-7-4-3-5-8-14)17(21(41)29-23-33-35-25(47-23)49(27,43)44)19(37-38)22(42)30-24-34-36-26(48-24)50(28,45)46/h3-11,31H,1-2H3,(H2,27,43,44)(H2,28,45,46)(H,29,33,41)(H,30,34,42)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	494	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dumlupinar University					Assay Description CA activity was measured according to the method described by Verpoorte et al. in inhibition studies, spectrophotometrically [Biochem., 242:4221-4229...				Bioorg Chem 68: 64-71 (2016) Article DOI: 10.1016/j.bioorg.2016.07.006 BindingDB Entry DOI: 10.7270/Q2N29VQC
					More data for this Ligand-Target Pair
Carbonic anhydrase 1 (Homo sapiens (Human))	BDBM193737 (1-(3-(2-(2,4-Dioxopentan-3-ylidene)hydrazinyl)phen...) Show SMILES [#6]-[#6](=O)-[#6](=[#7]/[#7]-c1cccc(c1)-n1nc(-[#6](=O)-[#7]-c2nnc(s2)S([#7])(=O)=O)c(-[#6](=O)-[#7]-c2nnc(s2)S([#7])(=O)=O)c1-c1ccccc1)\[#6](-[#6])=O Show InChI InChI=1S/C26H22N12O8S4/c1-12(39)18(13(2)40)32-31-15-9-6-10-16(11-15)38-20(14-7-4-3-5-8-14)17(21(41)29-23-33-35-25(47-23)49(27,43)44)19(37-38)22(42)30-24-34-36-26(48-24)50(28,45)46/h3-11,31H,1-2H3,(H2,27,43,44)(H2,28,45,46)(H,29,33,41)(H,30,34,42)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	767	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dumlupinar University					Assay Description CA activity was measured according to the method described by Verpoorte et al. in inhibition studies, spectrophotometrically [Biochem., 242:4221-4229...				Bioorg Chem 68: 64-71 (2016) Article DOI: 10.1016/j.bioorg.2016.07.006 BindingDB Entry DOI: 10.7270/Q2N29VQC
					More data for this Ligand-Target Pair